Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Tax Withholding | 2024-10-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 84 | $1.88 | 131,567 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-03 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 92 | $1.92 | 131,651 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:08 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 94 | $3.08 | 131,743 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:22 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 93 | $2.28 | 194,337 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:22 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 62,500 | $0 | 194,337 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:11 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 62,500 | $0 | 131,930 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 4:26 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 1,087 | $3.83 | 6,930 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-05 4:37 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 91 | $4.1 | 8,017 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:07 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 384 | $3.08 | 8,108 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 354 | $0.15 | 173,005 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 353 | $0.223 | 173,359 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:01 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 354 | $0.389 | 173,712 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:36 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 12,510 | $0.3463 | 174,066 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:10 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 773 | $0.65 | 161,556 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:10 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO | 75,000 | $0 | 237,329 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:40 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 206 | $1.02 | 87,329 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 5:08 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 4,187 | $0.8755 | 87,535 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 5:12 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 206 | $1.39 | 83,348 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 5:35 pm | N/A 2031-09-02 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 121,719 | $0 | 144,414 (Direct) | View |
| 2021-06-30 Tax Withholding | 2021-07-02 4:37 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 700 | $3.51 | 22,695 (Direct) | View |
Ownership | 2021-06-21 5:19 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO | 0 | $0 | 69,483 (Direct) | View |